Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 2, 2006, Pages

  Chelikani, Prasanth K ^b   Haver, Alvin C ^a   Reeve Jr , Joseph R ^c,d   Keire, David A ^c,d   Reidelberger, Roger D ^a,b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body composition; Body weight; Gastrointestinal

Indexed keywords

PEPTIDE YY; PEPTIDE YY [3-36]; UNCLASSIFIED DRUG; PEPTIDE YY (3 36); PEPTIDE YY (3-36);

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; COMPUTER SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOOD INTAKE; MALE; MEAL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PUMP DESIGN; RAT; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; DRUG ADMINISTRATION; FEEDING BEHAVIOR; INTRAVENOUS DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADIPOSITY; ANIMALS; DRUG ADMINISTRATION SCHEDULE; FEEDING BEHAVIOR; INJECTIONS, INTRAVENOUS; MALE; PEPTIDE YY; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN;

EID: 33644849354     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00674.2005     Document Type: Article

References (40)

1. Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, and Bloom SR. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044: 127-131, 2005.
2. Al Barazanji KA, Arch JR, Buckingham RE, and Tadayyon M. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats. Obes Res 8: 317-323, 2000.
3. AOAC International. Official Methods of Analysis. 16 (3rd Revision). AOAC International, Gaithersburg, MD, 1997.
4. Arnelo U, Permert J, Adrian TE, Larsson J, Westermark P, and Reidelberger RD. Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am J Physiol Regul Integr Comp Physiol 271: R1654-R1659, 1996.
5. Badman MK and Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science 307: 1909-1914, 2005.
6. Barnes EM Jr. Use-dependent regulation of GABAA receptors. Int Rev Neurobiol 39: 53-76, 1996.
7. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, and Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
8. Broome M, Hokfelt T, and Terenius L. Peptide YY (PYY)-immunoreactive neurons in the lower brain stem and spinal cord of rat. Acta Physiol Scand 125: 349-352, 1985.
9. Chelikani PK, Haver AC, and Reidelberger RD. Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 287: R1064-R1070, 2004.
10. Chelikani PK, Haver AC, and Reidelberger RD. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146: 879-888, 2005.
11. Crawley JN and Beinfeld MC. Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature 302: 703-706, 1983.
12. Donahey JC, van Dijk G, Woods SC, and Seeley RJ. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res 779: 75-83, 1998.
13. 125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 22: 139-158, 1996.
14. Eison AS and Mullins UL. Regulation of central 5-HT2A receptors: a review of in vivo studies. Behav Brain Res 73: 177-181, 1996.
15. Ekblad E and Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 23: 251-261, 2002.
16. Ekman R, Wahlestedt C, Bottcher G, Sundler F, Hakanson R, and Panula P. Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 16: 157-168, 1986.
17. Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutr Rev 60: S1-14, 2002.
18. Gehlert DR and Gackenheimer SL. Differential distribution of neuropeptide Y Y1 and Y2 receptors in rat and guinea-pig brains. Neuroscience 76: 215-224, 1997.
19. Grady EF, Bohm SK, and Bunnett NW. Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors. Am J Physiol Gastrointest Liver Physiol 273: G586-G601, 1997.
20. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, and Reeve JR Jr. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51: 151-159, 1994.
21. Grandt D, Teyssen S, Schimiczek M, Reeve JR Jr, Feth F, Rascher W, Hirche H, Singer MV, Layer P, Goebell H, Ho FJ, and Eysselein VE. Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophys Res Commun 186: 1299-1306, 1992.
22. Gura T. Obesity research: new data on appetite-suppressing peptide challenge critics. Science 306: 1453-1454, 2004.
23. Koda S, Date Y, Murakami N, Shimbara T, Hanada T, Toshinai K, Niijima A, Furuya M, Inomata N, Osuye K, and Nakazato M. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146: 2369-2375, 2005.
24. Lin HC, Neevel C, and Chen JH. Slowing intestinal transit by PYY depends on serotonergic and opioid pathways. Am J Physiol Gastrointest Liver Physiol 286: G558-G563, 2004.
25. Lukaszewski L and Praissman M. Effect of continuous infusions of CCK-8 on food intake and body and pancreatic weights in rats. Am J Physiol Regul Integr Comp Physiol 254: R17-R22, 1988.
26. Martin BR, Sim-Selley LJ, and Selley DE. Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol Sci 25: 325-330, 2004.
27. Miyachi Y, Jitsuishi W, Miyoshi A, Fujita S, Mizuchi A, and Tatemoto K. The distribution of polypeptide YY-like immunoreactivity in rat tissues. Endocrinology 118: 2163-2167, 1986.
28. Moran TH and Kinzig KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286: G183-G188, 2004.
29. Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, and Ladenheim EE. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 288: R384-R388, 2005.
30. Nonaka N, Shioda S, Niehoff ML, and Banks WA. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J Pharmacol Exp Ther 306: 948-953, 2003.
31. Pittner RA, Moore CX, Bhavsar SP, Gedulin BR, Smith PA, Jodka CM, Parkes DG, Paterniti JR, Srivastava VP, and Young AA. Effects of PYY[3-36] in rodent models of diabetes and obesity. Int J Obes Relat Metab Disord 28: 963-971, 2004.
32. Powley TL and Phillips RJ. Gastric satiation is volumetric, intestinal satiation is nutritive. Physiol Behav 82: 69-74, 2004.
33. Ritter RC. Gastrointestinal mechanisms of satiation for food. Physiol Behav 81: 249-273, 2004.
34. Salva LP, Garcia Vicente JA, Costa PJ, and Lucio MP. Causes and problems of nonresponse or poor response to drugs. Drugs 51: 552-570, 1996.
35. Savage AP, Adrian TE, Carolan G, Chatterjee VK, and Bloom SR. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28: 166-170, 1987.
36. Shechter Y, Tsubery H, Mironchik M, Rubinstein M, and Fridkin M. Reversible PEGylation of peptide YY(3-36) prolongs its inhibition of food intake in mice. FEBS Lett 579: 2439-2444, 2005.
37. 35S] GTPγS autoradiography in rat brain. J Neurosci 16: 2684-2692, 1996.
38. Strader AD and Woods SC. Gastrointestinal hormones and food intake. Gastroenterology 128: 175-191, 2005.
39. Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-Sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, and Heiman ML. Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 430: 1-3, 2004.
40. Woltman T, Castellanos D, and Reidelberger R. Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats. Am J Physiol Regul Integr Comp Physiol 269: R1420-R1433, 1995.